Which CYP2B6 Variants Have Functional Consequences for Cyclophosphamide Bioactivation?

被引：9
|
作者：
Helsby, Nuala A. [1 ]
Tingle, Malcolm D. [1 ]
机构：
[1] Univ Auckland, Fac Med & Hlth Sci, Auckland 1, New Zealand
来源：
DRUG METABOLISM AND DISPOSITION | 2012年 / 40卷 / 03期
关键词：
BREAST-CANCER PATIENTS; PULSE CYCLOPHOSPHAMIDE; CYTOCHROME P4502C19; LUPUS NEPHRITIS; POLYMORPHISMS; PHARMACOGENETICS; TOXICITY; CYP2C19; METABOLISM; GENOTYPE;
D O I：
10.1124/dmd.111.043646
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：635 / 637
页数：3
相关论文
共 50 条
  • [1] Bioactivation of chlorpyrifos by CYP2B6 variants
    Crane, Alice L.
    Klein, Kathrin
    Olson, James R.
    [J]. XENOBIOTICA, 2012, 42 (12) : 1255 - 1262
  • [2] Role of polymorphic human CYP2B6 in cyclophosphamide bioactivation
    H-J Xie
    Ü Yasar
    S Lundgren
    L Griskevicius
    Y Terelius
    M Hassan
    A Rane
    [J]. The Pharmacogenomics Journal, 2003, 3 : 53 - 61
  • [3] Role of polymorphic human CYP2B6 in cyclophosphamide bioactivation
    Xie, HJ
    Yasar, Ü
    Lundgren, S
    Griskevicius, L
    Terelius, Y
    Hassan, M
    Rane, A
    [J]. PHARMACOGENOMICS JOURNAL, 2003, 3 (01): : 53 - 61
  • [4] Role of polyphorphic human CYP2B6 in cyclophosphamide bioactivation
    Xie, HJ
    Yasar, Ü
    Lundgren, S
    Griskevicius, L
    Terelius, Y
    Hassan, M
    Rane, A
    [J]. DRUG METABOLISM REVIEWS, 2003, 35 : 129 - 129
  • [5] The combined impact of CYP2C19 and CYP2B6 pharmacogenetics on cyclophosphamide bioactivation
    Helsby, Nuala A.
    Hui, Chung-Yee
    Goldthorpe, Michael A.
    Coller, Janet K.
    Soh, May Ching
    Gow, Peter J.
    de Zoysa, Janak Z.
    Tingle, Malcolm D.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 70 (06) : 844 - 853
  • [6] The role of human CYP2B6 polymorphism in the bioactivation of cyclophosphamide using CDNA expressed enzymes
    Afsharian, P.
    Teredius, Y.
    Hidestrand, M.
    Ingelman-Sundberg, M.
    Hassan, M.
    Lundgren, S.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 70 - 71
  • [7] Cytochrome P450 Oxidoreductase Influences CYP2B6 Activity in Cyclophosphamide Bioactivation
    El-Serafi, Ibrahim
    Afsharian, Parvaneh
    Moshfegh, Ali
    Hassan, Moustapha
    Terelius, Ylva
    [J]. PLOS ONE, 2015, 10 (11):
  • [8] Functional Characterization of CYP2B6 Allelic Variants in Demethylation of Antimalarial Artemether
    Honda, Masashi
    Muroi, Yuka
    Tamaki, Yuichiro
    Saigusa, Daisuke
    Suzuki, Naoto
    Tomioka, Yoshihisa
    Matsubara, Yoichi
    Oda, Akifumi
    Hirasawa, Noriyasu
    Hiratsuka, Masahiro
    [J]. DRUG METABOLISM AND DISPOSITION, 2011, 39 (10) : 1860 - 1865
  • [9] The importance of correct assignment of CYP2B6 genetic variants with respect to cyclophosphamide metabolizer status
    Helsby, Nuala
    Tingle, Malcolm
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2011, 86 (04) : 383 - 384
  • [10] Differences in Methadone Metabolism by CYP2B6 Variants
    Gadel, Sarah
    Friedel, Christina
    Kharasch, Evan D.
    [J]. DRUG METABOLISM AND DISPOSITION, 2015, 43 (07) : 994 - 1001
12345